These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10705053)

  • 1. Screening and confirmatory testing for extended spectrum beta-lactamases (ESBL) in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca clinical isolates.
    Hadziyannis E; Tuohy M; Thomas L; Procop GW; Washington JA; Hall GS
    Diagn Microbiol Infect Dis; 2000 Feb; 36(2):113-7. PubMed ID: 10705053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can results obtained with commercially available MicroScan microdilution panels serve as an indicator of beta-lactamase production among escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonam?
    Moland ES; Sanders CC; Thomson KS
    J Clin Microbiol; 1998 Sep; 36(9):2575-9. PubMed ID: 9705395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
    Zarakolu P; Metan G; Hasçelik G; Akova M
    Mikrobiyol Bul; 2007 Oct; 41(4):579-84. PubMed ID: 18173077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Clinical and Laboratory Standards Institute phenotypic confirmatory test to detect the presence of extended-spectrum β-lactamases from 4005 Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoniae and Proteus mirabilis isolates.
    Morrissey I; Bouchillon SK; Hackel M; Biedenbach DJ; Hawser S; Hoban D; Badal RE
    J Med Microbiol; 2014 Apr; 63(Pt 4):556-561. PubMed ID: 24478449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center.
    Del Carmen Rodríguez M; Vera DE; Ramírez-Ronda CH; Saavedra S
    P R Health Sci J; 2004 Sep; 23(3):207-15. PubMed ID: 15631176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the NCCLS extended-spectrum beta-lactamase confirmation methods for Escherichia coli with isolates collected during Project ICARE.
    Tenover FC; Raney PM; Williams PP; Rasheed JK; Biddle JW; Oliver A; Fridkin SK; Jevitt L; McGowan JE;
    J Clin Microbiol; 2003 Jul; 41(7):3142-6. PubMed ID: 12843054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
    Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
    J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of screening methods for detection of extended-spectrum beta-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital.
    Vercauteren E; Descheemaeker P; Ieven M; Sanders CC; Goossens H
    J Clin Microbiol; 1997 Sep; 35(9):2191-7. PubMed ID: 9276386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp. from intensive care units in Europe.
    Livermore DM; Yuan M
    J Antimicrob Chemother; 1996 Sep; 38(3):409-24. PubMed ID: 8889716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
    Kuzucu C; Yetkin F; Görgeç S; Ersoy Y
    Mikrobiyol Bul; 2011 Jan; 45(1):28-35. PubMed ID: 21341156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of extended-spectrum-β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates that test susceptible to cephalosporins and aztreonam by the revised CLSI breakpoints.
    McWilliams CS; Condon S; Schwartz RM; Ginocchio CC
    J Clin Microbiol; 2014 Jul; 52(7):2653-5. PubMed ID: 24789185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of cefepime, cefotaxime, ceftazidime, and aztreonam against extended-spectrum-producing isolates of Klebsiella pneumoniae and Escherichia coli from Chilean hospitals.
    Zemelman C; Bello H; Domínguez M; González G; Mella S; Zemelman R
    Diagn Microbiol Infect Dis; 2001; 40(1-2):41-3. PubMed ID: 11448562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of extended-spectrum beta-lactamases among Escherichia coli and Klebsiella pneumoniae isolates in a tertiary care hospital.
    Agrawal P; Ghosh AN; Kumar S; Basu B; Kapila K
    Indian J Pathol Microbiol; 2008; 51(1):139-42. PubMed ID: 18417887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended spectrum b lactamases (ESBL) in clinical isolates of Klebsiella pneumoniae and Escherichia coli.
    Duttaroy B; Mehta S
    Indian J Pathol Microbiol; 2005 Jan; 48(1):45-8. PubMed ID: 16758790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and reporting of organisms producing extended-spectrum beta-lactamases: survey of laboratories in Connecticut.
    Tenover FC; Mohammed MJ; Gorton TS; Dembek ZF
    J Clin Microbiol; 1999 Dec; 37(12):4065-70. PubMed ID: 10565933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nationwide study of mechanisms conferring reduced susceptibility to extended-spectrum cephalosporins in clinical Escherichia coli and Klebsiella spp. isolates.
    Tofteland S; Dahl KH; Aasnæs B; Sundsfjord A; Naseer U
    Scand J Infect Dis; 2012 Dec; 44(12):927-33. PubMed ID: 22991975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cephalosporin MIC distribution of extended-spectrum-{beta}-lactamase- and pAmpC-producing Escherichia coli and Klebsiella species.
    Kohner PC; Robberts FJ; Cockerill FR; Patel R
    J Clin Microbiol; 2009 Aug; 47(8):2419-25. PubMed ID: 19494061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum beta-lactamase detection methods.
    Steward CD; Rasheed JK; Hubert SK; Biddle JW; Raney PM; Anderson GJ; Williams PP; Brittain KL; Oliver A; McGowan JE; Tenover FC
    J Clin Microbiol; 2001 Aug; 39(8):2864-72. PubMed ID: 11474005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence of extended-spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae from Daejeon].
    Ko CS; Sung JY; Koo SH; Kwon GC; Shin SY; Park JW
    Korean J Lab Med; 2007 Oct; 27(5):344-50. PubMed ID: 18094599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility testing for Klebsiella pneumoniae isolates resistant to extended-spectrum beta-lactam antibiotics.
    Jan IS; Hsueh PR; Teng LJ; Ho SW; Luh KT
    J Formos Med Assoc; 1998 Oct; 97(10):661-6. PubMed ID: 9830274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.